Identification of clinically relevant yeasts by PCR/RFLP
Related Experiment Video
Updated: Aug 29, 2026
Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Anja Trost1, Barbara Graf, Jan Eucker
1Institute for Microbiology and Hygiene, Medical Faculty of Humboldt University, Charité, Dorotheenstr. 96, 10117 Berlin, Germany. thomas.adam@charite.de
Abstract:
For molecular diagnosis of fungal disease using DNA amplification procedures in the routine laboratory, choice of appropriate target structures and rapid and inexpensive identification of amplification products are important prerequisites. Most diagnostic procedures described thus far are characterized by limited applicability, considerable cost for laboratory equipment or low power of discrimination between species. This study aimed at identification of a PCR target appropriate for diagnosis of clinically relevant yeasts and an affordable procedure for characterization of the PCR products to the species level. Here, we describe a PCR-based system using amplification of intergenic spacers ITS1 and ITS2 and restriction length polymorphism of PCR products after sequence-specific enzymatic cleavage. We show the evaluation of the system for clinically relevant Candida species. The simple and inexpensive procedure should be instrumental for rapid identification of medically important yeasts.
Insights
This study introduces a simple and affordable polymerase chain reaction (PCR) method for identifying clinically relevant yeasts. The new technique uses intergenic spacer regions for rapid and accurate molecular diagnosis of fungal infections.
Area of Science:
- Medical Mycology
- Molecular Diagnostics
- Biotechnology
Background:
- Accurate and rapid molecular diagnosis of fungal infections is crucial in routine laboratories.
- Existing DNA amplification methods often have limitations in applicability, cost, and species discrimination.
- Efficient identification of amplification products is essential for timely and effective treatment.
Purpose of the Study:
- To identify a suitable Polymerase Chain Reaction (PCR) target for diagnosing clinically significant yeasts.
- To develop an affordable method for species-level characterization of PCR products.
- To evaluate the developed system for clinically relevant Candida species.
Main Methods:
- Utilized PCR to amplify intergenic spacer regions ITS1 and ITS2.
- Employed restriction fragment length polymorphism (RFLP) for PCR product characterization.
- Applied sequence-specific enzymatic cleavage for precise identification.
- Evaluated the system's performance on clinically relevant Candida species.
Main Results:
- Successfully identified a specific PCR target suitable for yeast diagnosis.
- Developed a cost-effective procedure for species-level identification of yeasts.
- Demonstrated the system's efficacy in differentiating clinically important Candida species.
- The method proved to be simple, rapid, and inexpensive.
Conclusions:
- The developed PCR-RFLP system offers a valuable tool for the molecular diagnosis of fungal diseases.
- This simple and inexpensive procedure facilitates the rapid identification of medically important yeasts in clinical settings.
- The system addresses the limitations of current diagnostic methods, improving laboratory efficiency and patient care.
Related Concept Videos
02:57Real Time RT-PCR
The real-time quantification of the number of amplified products is...
01:28Methods of Classification and Identification